Filter
1895
Text search:
SARS-CoV-2
Featured
275
4
Language
Document type
751
329
290
108
99
94
67
38
36
31
23
20
9
Countries / Regions
151
125
87
81
73
59
58
52
42
41
39
37
37
35
35
33
30
29
28
25
23
23
23
22
22
21
16
15
14
13
12
12
12
11
11
10
10
10
9
9
9
9
9
9
8
8
8
8
7
7
7
7
6
6
6
6
6
5
5
5
5
5
5
5
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
991
48
36
30
28
25
15
2
Toolboxes
1573
55
28
26
25
18
18
14
11
10
10
10
9
8
8
6
6
4
4
2
2
1
These WHO interim recommendations on the use of the Astra Zeneca – Oxford University AZD1222 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenc
...
A Global Analysis of Antimicrobial Resistance and Its Drivers.
Since the first State of the World’s Antibiotics report in 2015, antimicrobial resistance has leveled off in some high-income countries but continues to rise in many low- and middle-income countries (LMICs), where access to antibiotic
...
Dies ist der fünfte Bericht, den das Deutsche Institut für Menschenrechte in seiner Funktion als Nationale Menschenrechtsinstitution Deutschlands dem Deutschen Bundestag vorlegt. Der Bericht erfasst den Zeitraum vom 1. Juli 2019 bis zum 30. Juni 2020. Aus den vielfältigen menschenrechtlichen Frag
...
VOX Sanguinis, 2021:
The coronavirus disease 2019 (COVID-19) affected millions of people worldwide and caused disruptions at the global level including in healthcare provision. Countries of the WHO African region have put in place measures for the COVID-19 pandemic containment that may adversely a
...
Archives of Disease in Childhood 2021;106:238-240.
1 February 2021 to 31 January 2022
Workplaces have played an important role in both the spread and mitigation of the COVID-19 pandemic throughout the world. Being provided a healthy and safe workplace throughout the pandemic and beyond is a human right. Maintaining open, safe and healthy workplaces is of vital importance to protectin
...
WHO Living guideline: Drugs to prevent COVID-19
recommended
Interim guidance 2 march 2021
Current use of drugs to prevent COVID-19 is variable, reflecting large-scale uncertainty. Numerous randomized trials of many different drugs are underway to inform practice. This first version of the Drugs to prevent COVID-19: A WHO living guideline contains new inform
...
Vaccines 2021, 9(2), 160; https://doi.org/10.3390/vaccines9020160
AstraZeneca-SKBio in South Korea and Serum Institute of India
This assessment tool is to support municipalities and local authorities in identifying the risks and vulnerabilities that refugees and migrants face and to identify gaps where possible methods to minimize the impact of the pandemic exist so that they can be prioritized within local policy processes.
...
This document is an update of the guidance published on 21 March 2020 and contains new evidence and guidance.
28 January 2021. The purpose of this document is to provide interim guidance on laboratory biosafety related to the testing of clinical specimens of patients.
21 August 2020
This guidance provides specific considerations for the use of non-medical masks, also known as fabric masks, by children as a means for source control in the context of the current COVID-19 pandemic. It also advises on the use of medical masks for children under certain conditions.
